NCT and Heidelberg University Hospital 1 article published in JoVE Cancer Research Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo Johannes P.W. Heidbuechel1,2, Christine E. Engeland1,3 1Department of Translational Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 2Faculty of Biosciences, Heidelberg University, 3Department of Medical Oncology, NCT and Heidelberg University Hospital This protocol describes a detailed workflow for the generation and ex vivo characterization of oncolytic viruses for expression of immunomodulators, using measles viruses encoding bispecific T cell engagers as an example. Application and adaptation to other vector platforms and transgenes will accelerate the development of novel immunovirotherapeutics for clinical translation.
